Log In
Print
BCIQ
Print
Print this Print this
 

Cerdelga, eliglustat tartrate (formerly Genz-112638)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionCeramide analog that inhibits glucosylceramide synthase (GCS)
Molecular Target Glucosylceramide synthase (GCS)
Mechanism of ActionGlucosylceramide synthase (GCS) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationGaucher's disease
Indication DetailsTreat Gaucher's disease; Treat Type I Gaucher's disease
Regulatory Designation

U.S. - Priority Review (Treat Type I Gaucher's disease);
EU - Standard Review (Treat Type I Gaucher's disease);
Japan - Orphan Drug (Treat Type I Gaucher's disease)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today